Early response to benralizumab in Canadian patients with severe eosinophilic asthma: Interim results from a prospective observational cohort

Stephen G. Noorduyna Department of Medical Affairs, AstraZeneca Canada, Mississauga, Ontario, Canada;b Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, CanadaView further author information

Sheena Kayaniyila Department of Medical Affairs, AstraZeneca Canada, Mississauga, Ontario, CanadaView further author information

Brett Lancastera Department of Medical Affairs, AstraZeneca Canada, Mississauga, Ontario, CanadaView further author information

Delbert Dorscheidc Center for Heart Lung Innovation, St. Paul ‘s Hospital, Vancouver, British Columbia, Canada

https://orcid.org/0000-0002-0680-0258 View further author information

Olga Tourind U-Breathe Clinic, Calgary, Alberta, CanadaView further author information

Brandie Walkere Health Research and Innovation Centre, University of Calgary, Calgary, Alberta, CanadaView further author information

Amin Thawerf Peak Medical Group, Red Deer, Alberta, CanadaView further author information

Warren Rameshg Edmonton Respiratory Consultants, Edmonton, Alberta, CanadaView further author information

Irfan Khanh North Bay Regional Health Centre, North Bay, Ontario, CanadaView further author information

Harold Kimi Division of Clinical Immunology and Allergy, Western University, London, Ontario, Canada;j Department of Medicine, McMaster University, Hamilton, Ontario, CanadaView further author information

Gordon Sussmank Gordon Sussman Clinical Research Inc, Toronto, Ontario, CanadaView further author information

Lawrence Mbuagbawb Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, CanadaView further author information

Erika Penzl Division of Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, CanadaCorrespondence[email protected]

https://orcid.org/0000-0003-2610-8450 View further author information

show all

Early response to benralizumab in Canadian patients with severe eosinophilic asthma: Interim results from a prospective observational cohort

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Early response to benralizumab in Canadian patients with severe eosinophilic asthma: Interim results from a prospective observational cohort

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date